annual operating expenses:
$24.35B-$68.00M(-0.28%)Summary
- As of today (May 20, 2025), NVS annual total operating expenses is $24.35 billion, with the most recent change of -$68.00 million (-0.28%) on December 31, 2024.
- During the last 3 years, NVS annual operating expenses has risen by +$2.17 billion (+9.77%).
- NVS annual operating expenses is now -17.77% below its all-time high of $29.61 billion, reached on December 31, 2011.
Performance
NVS Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$5.73B-$974.00M(-14.53%)Summary
- As of today (May 20, 2025), NVS quarterly total operating expenses is $5.73 billion, with the most recent change of -$974.00 million (-14.53%) on March 31, 2025.
- Over the past year, NVS quarterly operating expenses has increased by +$79.00 million (+1.40%).
- NVS quarterly operating expenses is now -34.73% below its all-time high of $8.78 billion, reached on December 31, 2011.
Performance
NVS quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NVS Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -0.3% | +1.4% |
3 y3 years | +9.8% | -6.2% |
5 y5 years | -3.2% | -8.2% |
NVS Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -0.3% | +9.8% | -20.6% | +5.4% |
5 y | 5-year | -3.2% | +9.8% | -20.6% | +49.0% |
alltime | all time | -17.8% | +151.2% | -34.7% | +158.1% |
NVS Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $5.73B(-14.5%) |
Dec 2024 | $24.35B(-0.3%) | $6.70B(+6.2%) |
Sep 2024 | - | $6.31B(+11.0%) |
Jun 2024 | - | $5.68B(+0.6%) |
Mar 2024 | - | $5.65B(-8.4%) |
Dec 2023 | $24.42B(+2.0%) | $6.17B(-14.4%) |
Sep 2023 | - | $7.21B(+28.9%) |
Jun 2023 | - | $5.60B(+2.9%) |
Mar 2023 | - | $5.44B(-11.9%) |
Dec 2022 | $23.93B(+7.9%) | $6.17B(+1.4%) |
Sep 2022 | - | $6.08B(-14.4%) |
Jun 2022 | - | $7.11B(+16.4%) |
Mar 2022 | - | $6.11B(+58.8%) |
Dec 2021 | $22.18B(-9.9%) | $3.85B(-37.9%) |
Sep 2021 | - | $6.20B(+5.0%) |
Jun 2021 | - | $5.90B(-5.4%) |
Mar 2021 | - | $6.24B(+1.2%) |
Dec 2020 | $24.63B(-2.1%) | $6.17B(-3.2%) |
Sep 2020 | - | $6.37B(+9.1%) |
Jun 2020 | - | $5.84B(-6.4%) |
Mar 2020 | - | $6.24B(-9.5%) |
Dec 2019 | $25.17B(+8.5%) | $6.90B(+8.7%) |
Sep 2019 | - | $6.35B(+6.6%) |
Jun 2019 | - | $5.96B(-0.1%) |
Mar 2019 | - | $5.96B(-8.2%) |
Dec 2018 | $23.19B(+10.0%) | $6.50B(+14.3%) |
Sep 2018 | - | $5.68B(+0.4%) |
Jun 2018 | - | $5.66B(+6.0%) |
Mar 2018 | - | $5.34B(+59.8%) |
Dec 2017 | $21.07B(-10.9%) | $3.34B(-44.4%) |
Sep 2017 | - | $6.01B(+0.9%) |
Jun 2017 | - | $5.96B(+3.4%) |
Mar 2017 | - | $5.76B(-13.6%) |
Dec 2016 | $23.65B(-1.5%) | $6.66B(+16.8%) |
Sep 2016 | - | $5.70B(-7.0%) |
Jun 2016 | - | $6.13B(+19.2%) |
Mar 2016 | - | $5.15B(-21.8%) |
Dec 2015 | $24.01B(-4.7%) | $6.58B(+12.2%) |
Sep 2015 | - | $5.86B(-4.3%) |
Jun 2015 | - | $6.13B(+12.7%) |
Mar 2015 | - | $5.44B(-17.5%) |
Dec 2014 | $25.20B(+0.2%) | $6.59B(+7.3%) |
Sep 2014 | - | $6.14B(-3.9%) |
Jun 2014 | - | $6.39B(+4.9%) |
Mar 2014 | - | $6.09B(-11.4%) |
Dec 2013 | $25.15B(+2.3%) | $6.87B(+10.4%) |
Sep 2013 | - | $6.22B(+1.0%) |
Jun 2013 | - | $6.16B(-8.1%) |
Mar 2013 | - | $6.70B(+46.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | $24.60B(-16.9%) | $4.57B(-29.9%) |
Sep 2012 | - | $6.52B(-4.5%) |
Jun 2012 | - | $6.82B(+1.9%) |
Mar 2012 | - | $6.69B(-23.8%) |
Dec 2011 | $29.61B(+15.9%) | $8.78B(+20.3%) |
Sep 2011 | - | $7.29B(+1.6%) |
Jun 2011 | - | $7.18B(+13.0%) |
Mar 2011 | - | $6.36B(-14.9%) |
Dec 2010 | $25.55B(+11.4%) | $7.47B(+13.7%) |
Sep 2010 | - | $6.57B(+14.2%) |
Jun 2010 | - | $5.75B(+0.1%) |
Mar 2010 | - | $5.75B(-16.0%) |
Dec 2009 | $22.94B(+3.4%) | $6.84B(+23.2%) |
Sep 2009 | - | $5.55B(-0.0%) |
Jun 2009 | - | $5.55B(+11.2%) |
Mar 2009 | - | $4.99B(-14.4%) |
Dec 2008 | $22.18B(+5.0%) | $5.83B(+2.8%) |
Sep 2008 | - | $5.67B(+1.4%) |
Jun 2008 | - | $5.59B(+10.1%) |
Mar 2008 | - | $5.08B(-25.9%) |
Dec 2007 | $21.13B(+17.1%) | $6.85B(+44.5%) |
Sep 2007 | - | $4.74B(-2.4%) |
Jun 2007 | - | $4.86B(+6.7%) |
Mar 2007 | - | $4.55B(-13.3%) |
Dec 2006 | $18.05B(+14.2%) | $5.25B(+16.3%) |
Sep 2006 | - | $4.52B(+7.1%) |
Jun 2006 | - | $4.22B(+7.9%) |
Mar 2006 | - | $3.91B(+2.8%) |
Dec 2005 | $15.81B(+9.3%) | $3.80B(-8.4%) |
Sep 2005 | - | $4.15B(+2.6%) |
Jun 2005 | - | $4.05B(+6.3%) |
Mar 2005 | - | $3.81B(+7.6%) |
Dec 2004 | $14.46B(+12.6%) | $3.54B(-5.0%) |
Sep 2004 | - | $3.73B(+4.0%) |
Jun 2004 | - | $3.58B(-0.7%) |
Mar 2004 | - | $3.61B(+10.3%) |
Dec 2003 | $12.84B(+19.0%) | $3.27B(+1.0%) |
Sep 2003 | - | $3.24B(-2.3%) |
Jun 2003 | - | $3.32B(+10.3%) |
Mar 2003 | - | $3.01B(+4.7%) |
Dec 2002 | $10.79B(+11.3%) | $2.87B(+10.2%) |
Sep 2002 | - | $2.61B(-8.8%) |
Jun 2002 | - | $2.86B(+25.4%) |
Dec 2001 | $9.69B(-11.5%) | - |
Jun 2001 | - | $2.28B(+2.7%) |
Dec 2000 | $10.96B(+3.8%) | - |
Jun 2000 | - | $2.22B |
Dec 1999 | $10.55B(-1.4%) | - |
Dec 1998 | $10.70B | - |
FAQ
- What is Novartis AG annual total operating expenses?
- What is the all time high annual operating expenses for Novartis AG?
- What is Novartis AG annual operating expenses year-on-year change?
- What is Novartis AG quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Novartis AG?
- What is Novartis AG quarterly operating expenses year-on-year change?
What is Novartis AG annual total operating expenses?
The current annual operating expenses of NVS is $24.35B
What is the all time high annual operating expenses for Novartis AG?
Novartis AG all-time high annual total operating expenses is $29.61B
What is Novartis AG annual operating expenses year-on-year change?
Over the past year, NVS annual total operating expenses has changed by -$68.00M (-0.28%)
What is Novartis AG quarterly total operating expenses?
The current quarterly operating expenses of NVS is $5.73B
What is the all time high quarterly operating expenses for Novartis AG?
Novartis AG all-time high quarterly total operating expenses is $8.78B
What is Novartis AG quarterly operating expenses year-on-year change?
Over the past year, NVS quarterly total operating expenses has changed by +$79.00M (+1.40%)